Evolution Biotechnologies
A UK-based company developing environmentally focused biological control solutions adapted from agricultural biopesticide platforms to address house dust mite infestations and the associated allergens that contribute to asthma and other allergic conditions. The company holds awarded patents covering the use, isolation, formulation and application of self‑amplifying acaricidal infectious agents and pursues commercial development via licensing.
Industries
Nr. of Employees
small (1-50)
Evolution Biotechnologies
Bedford, Bedfordshire, United Kingdom, Europe
Patents
Products
House dust mite biological control development program
A development program to create environmentally oriented biological control solutions targeting house dust mites and their allergens, including agent discovery, formulation and methods of application.
ACARICIDES
Biological control technology platform and acaricide treatments targeting house dust mites to reduce asthma and allergy triggers.
House dust mite biological control development program
A development program to create environmentally oriented biological control solutions targeting house dust mites and their allergens, including agent discovery, formulation and methods of application.
ACARICIDES
Biological control technology platform and acaricide treatments targeting house dust mites to reduce asthma and allergy triggers.
Services
Granting development and commercial licences for patented methods and biological agent formulations targeting house dust mites.
Granting development and commercial licences for patented methods and biological agent formulations targeting house dust mites.
Expertise Areas
- Biopesticide and biological control R&D
- Acaricide (house dust mite) agent development
- Formulation and delivery for domestic environments
- Environmental safety and target specificity assessment
Key Technologies
- Virus‑based biocontrol platforms
- Self‑amplifying biological agents
- Agent isolation and screening methods
- Formulation chemistry for biopesticides
News & Updates
Patents deriving from PCT filing WO2017025732A1 awarded in jurisdictions including the USA, UK, EU, Switzerland, Hong Kong, Japan and Australia.
Patents deriving from PCT filing WO2017025732A1 awarded in jurisdictions including the USA, UK, EU, Switzerland, Hong Kong, Japan and Australia.